Kala Pharmaceuticals

Kala Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.07-$1,030
Market Cap
$21.8M
Shares Short
218,549

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$1.3M
Diluted EPS
-$102.01

News

See more

Yahoo Finance • 4 months ago

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

Yahoo Finance • 4 months ago

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Yahoo Finance • 4 months ago

KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgency”

Yahoo Finance • 7 months ago

KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

About

CEO
Mr. Avi Minkowitz
CFO
Mr. Avi Minkowitz
Address
1167 Massachusetts Avenue, Arlington, MA, United States, 02476
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
6